Modular diagnostic assay

The modular diagnostic assay system addresses the challenge of inadequate diagnostic infrastructure in limited resource settings by providing a manually operated, electricity-free system for rapid and sensitive diagnosis of infectious diseases, achieving high sensitivity and specificity.

WO2026107450A2PCT designated stage Publication Date: 2026-05-21CHROMOLOGIC LLC
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
CHROMOLOGIC LLC
Filing Date
2025-11-17
Publication Date
2026-05-21

AI Technical Summary

Technical Problem

The infrastructure for rapid and precise diagnostic testing of infectious diseases, particularly in limited resource settings, is inadequate, posing challenges for timely diagnosis of diseases like malaria and other neglected tropical diseases.

Method used

A modular diagnostic assay system that includes a fluidic subsystem, molecular biology subsystem, and heating subsystem, utilizing a manually operated fluidic device with check valves, isothermal nucleic acid amplification, and CRISPR recognition, enabling self-administered diagnosis without electricity, with a visual readout.

Benefits of technology

The system achieves rapid and sensitive diagnosis of infectious diseases, reaching a sensitivity of 10 parasites/pL within 1 hour, suitable for point-of-care testing in remote areas, and is scalable for various diseases.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure US2025055791_21052026_PF_FP_ABST
    Figure US2025055791_21052026_PF_FP_ABST
Patent Text Reader

Abstract

Systems and devices of a modular diagnostic assay are described. Various modular diagnostic assay structures and subsystems may be incorporated into an in vitro diagnostic device to diagnose diseases in limited resource sites at the point of care.
Need to check novelty before this filing date? Find Prior Art